Christopher R. Flowers, M.D.
The University of Texas M.D. Anderson Cancer Center
|Titles & Positions|
|Institutional & Related Links|
|Grant ID: RR190079|
Recruitment of Established Investigators
Emory University School of Medicine
August 21, 2019
Dr. Christopher R. Flowers joined The University of Texas MD Anderson Cancer Center in August 2019 as Department Chair of Lymphoma/Myeloma and was appointed Division Head ad interim of Cancer Medicine in August 2020. Prior to MD Anderson, he was professor of Hematology and Oncology with a joint appointment in Biomedical Informatics at Emory University School of Medicine in Atlanta. During his tenure there, he served the Winship Cancer Institute as director of the Emory Healthcare-Lymphoma Program for 13 years and as scientific director of Research Informatics for four years.
An internationally recognized expert in lymphoma clinical care, epidemiology and outcomes research, Dr. Flowers is an innovator who has a passion for facilitating new drug development. He is an active clinician who conducts clinical research involving cancer outcomes, cancer informatics, and phase 1/2 trials, focusing on the clinical development of novel therapeutics for B-cell lymphomas. His broader research interests include patient-oriented research in lymphoma and computer microsimulation models and cost-effectiveness analyses aimed at developing strategies to individualize care for cancer patients and improve systems of care. His work has resulted in >200 peer-reviewed publications. He has received peer-reviewed funding from foundations and the NIH including leading two U01 awards and two multi-institutional team science grants.